Cite
In silico docking analysis of CCL28 (C-C motif chemokine ligand 28) and astragalin as the potential inhibitor of rheumatoid arthritis [version 1; peer review: 1 approved, 1 approved with reservations]
MLA
Sadaf Noor, et al. “In Silico Docking Analysis of CCL28 (C-C Motif Chemokine Ligand 28) and Astragalin as the Potential Inhibitor of Rheumatoid Arthritis [Version 1; Peer Review: 1 Approved, 1 Approved with Reservations].” F1000Research, vol. 8, Mar. 2019, p. 313. EBSCOhost, https://doi.org/10.12688/f1000research.18541.1.
APA
Sadaf Noor, Syeda Tahira Qousain, & Syed Aun Muhammad. (2019). In silico docking analysis of CCL28 (C-C motif chemokine ligand 28) and astragalin as the potential inhibitor of rheumatoid arthritis [version 1; peer review: 1 approved, 1 approved with reservations]. F1000Research, 8, 313. https://doi.org/10.12688/f1000research.18541.1
Chicago
Sadaf Noor, Syeda Tahira Qousain, and Syed Aun Muhammad. 2019. “In Silico Docking Analysis of CCL28 (C-C Motif Chemokine Ligand 28) and Astragalin as the Potential Inhibitor of Rheumatoid Arthritis [Version 1; Peer Review: 1 Approved, 1 Approved with Reservations].” F1000Research 8 (March): 313. doi:10.12688/f1000research.18541.1.